|
(V112) |
Epidemiology and long-term outcome in ambulatory patients with chronic heart failure in north-western Europe |
| |
|
H. Fröhlich, N. Rosenfeld, T. Täger, K. Goode, S. Kazmi, T. Hole, H. A. Katus, J. G. F. Cleland, D. Atar, S. Agewall, A. Clark, M. Grundtvig, L. Frankenstein (Heidelberg; Hull, London, UK; Trondheim, Oslo, Lillehammer, NO) |
|
|
Diskussion |
|
(V113) |
Growth factor and atrophy-related gene expression in patients with HFpEF correlates with elevated BNP, reduced exercise capacity and quality of life |
| |
|
T. Bekfani, M. B. ELsaied, S. Derlien, A. Hamadanchi, J. Nisser, E. Fröb, D. Haase, T. Kretzschmar, M. Franz, U. C. Smolenski, G. Lehmann, G. Wolf, S. Möbius-Winkler, C. Schulze (Jena, Münster) |
|
|
Diskussion |
|
(V114) |
Altered mitochondrial function and morphology in skeletal muscle in patients with heart failure both with preserved and reduced ejection fraction |
| |
|
T. Bekfani, M. B. ELsaied, M. Westermann, S. Nietzsche, S. Derlien, A. Hamadanchi, J. Nisser, E. Fröb, D. Haase, T. Kretzschmar, M. Franz, U. C. Smolenski, G. Wolf, G. Lehmann, S. Möbius-Winkler, C. Schulze (Jena, 07743, Münster) |
|
|
Diskussion |
|
(V115) |
READY: Relative efficAcy of loop Diuretics in patients with chronic sYstolic heart failure – a systematic review and network meta-analysis of randomized trials |
| |
|
T. Täger, H. Fröhlich, M. Seiz, H. A. Katus, L. Frankenstein (Heidelberg) |
|
|
Diskussion |
|
(V116) |
Rapid Improvement in Left Ventricular Function after Sinus Rhythm Restoration in Patients with Idiopathic Cardiomyopathy and Atrial Fibrillation |
| |
|
B. Müller-Edenborn, J. Minners, J. Allgeier, T. Burkhard, H. Lehrmann, P. Ruile, S. Merz, M. Allgeier, F.-J. Neumann, A. S. Jadidi, N. Jander (Bad Krozingen; Basel, CH) |
|
|
Diskussion |
|
(V117) |
Enhanced Adrenomedullin Activity as an Alternate Mechanism of Action in ARNI Therapy |
| |
|
H. Arfsten, G. Goliasch, P. Bartko, A. Cho, J. Novak, H. Haslacher, J. Struck, G. Strunk, M. Hülsmann, N. Pavo (Wien, AT; Hennigsdof) |
|
|
Diskussion |
|
(V118) |
Pathophysiology of diaphragm involvement in systolic heart failure: insights from diaphragm ultrasound and phrenic nerve stimulation studies |
| |
|
J. Spießhöfer, C. Henke, I. Tuleta, S. Herkenrath, W. Randerath, P. Young, M. Boentert, A. Giannoni (Münster, Solingen; Pisa, IT) |
|
|
Diskussion |
|
(V119) |
Das DNA basierte Therapeutikum BC007 eliminiert funktionell aktive, pathogene Autoantikörper gegen G-Protein gekoppelte Rezeptoren bei Patienten mit Kardiomyopathie – Ergebnisse einer Phase 1 Studie |
| |
|
J. Mueller, A. Haberland, N.-P. Becker, K. Wenzel, G. Wallukat, P. Goettel, S. Schulze-Rothe, I. Schimke, G. Golor, M. Grossmann, A. Sinn, M. Steiper, T. Yilmaz, A. Wallukat, S. Becker (Berlin, Mannheim) |
|
|
Diskussion |
|
(V120) |
Phosphodiesterase 9A Expression in Patients with Heart Failure with Preserved Ejection Fraction: Results from Endomyocardial Biopsies and the Leipzig (LIFE) Heart Study Cohort |
| |
|
C. Besler, K.-P. Rommel, H. Kirsten, J. Mörbitz, K. Klingel, R. Burkhardt, J. Thiery, H. Thiele, M. Scholz, P. Lurz (Leipzig, Tübingen, Regensburg) |
|
|
Diskussion |